Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Danshen Dripping Pills for Ventricular Remodeling after Acute Anterior STEMI
ChiCTR2200060193Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in myocardial infarction (MI) comparing Compound Danshen dripping pills with Placebo (2 arms). Primary endpoints: Left ventricular ejection fraction at 1 year, Myocardial strain rate at 1 year and 1 more. Started May 2022; status: recruiting.
02
Drugs
Compound Danshen
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2200060193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060193.